You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 00054-0621


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00054-0621

Drug NameNDCPrice/Unit ($)UnitDate
ICOSAPENT ETHYL 0.5 GM CAPSULE 00054-0621-27 0.55728 EACH 2025-04-23
ICOSAPENT ETHYL 0.5 GM CAPSULE 00054-0621-27 0.54786 EACH 2025-03-19
ICOSAPENT ETHYL 0.5 GM CAPSULE 00054-0621-27 0.57578 EACH 2025-02-19
ICOSAPENT ETHYL 0.5 GM CAPSULE 00054-0621-27 0.60430 EACH 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 00054-0621

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
ICOSAPENT ETHYL 1GM CAP Nationwide Pharmaceutical LLC 00054-0621-27 240 147.82 0.61592 2023-04-10 - 2026-04-30 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for the Drug NDC: 00054-0621

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC represents. The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes information about the labeler, product, and package size[1][5].

Identifying the Drug

The NDC 00054-0621 corresponds to a specific drug product. However, without direct access to the FDA's NDC Directory, we cannot identify the exact drug name and details from the provided sources. Typically, you would look up this NDC in the FDA's National Drug Code Directory to find the drug's name, dosage form, strength, and other relevant details.

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is undergoing significant changes driven by technological advancements, regulatory shifts, and evolving patient needs.

Role of AI and Digital Tools

AI is revolutionizing drug development by accelerating the process of identifying potential compounds, predicting molecular structure changes, and reducing costs. By 2025, AI is expected to be an essential partner in research labs, enabling scientists to explore more options in a shorter time and speeding up the journey from lab to market[3].

Personalized and Precision Medicine

The industry is moving towards personalized medicine, with treatments designed for specific genetic codes. This trend is expected to continue, making patient care more tailored and effective[3].

Impact of Generic and Biosimilar Drugs

The introduction of generic and biosimilar drugs can significantly impact the market. For example, in the Non-Small Cell Lung Cancer (NSCLC) market, the patent expiration of blockbuster drugs like Tarceva and Alimta has led to a decline in their sales, while generic versions have seen an increase[4].

Price Projections and Market Analysis

Pricing Strategies

Companies like Dr. Reddy's Laboratories have demonstrated how pricing strategies can impact market positioning. For instance, Dr. Reddy's introduced Lenalidomide with a 14% reduction in price compared to the branded version, Revlimid, which helped in recouping costs, covering distribution, providing rebates, and earning a reasonable return on investment[2].

Market Forecast for Similar Therapeutic Areas

In the NSCLC market, premium-priced immune checkpoint inhibitors are driving growth. By 2025, these immunotherapies are projected to reach $17.5 billion in sales, with key players like Keytruda, Opdivo, and Tecentriq contributing significantly to this figure[4].

Factors Influencing Price Projections

Regulatory Compliance

Drug establishments must comply with FDA regulations, including updating drug listing data regularly. Non-compliance can result in a drug product not being included in the NDC Directory, which can affect market visibility and pricing[5].

Competition and Market Dynamics

The presence of generic and biosimilar drugs can reduce the prices of branded drugs. For example, the introduction of generic erlotinib and pemetrexed has reduced the sales of their branded counterparts in the NSCLC market[4].

Technological Advancements

Technologies like AI, gene editing, and blockchain are making drug development faster and more efficient. These advancements can lead to lower development costs and potentially influence pricing strategies[3].

Key Takeaways

  • NDC Importance: The NDC is crucial for identifying and tracking drug products, and its database is updated daily by the FDA.
  • Market Trends: AI, personalized medicine, and digital tools are reshaping the pharmaceutical industry.
  • Pricing Strategies: Companies can impact market positioning through strategic pricing, such as offering discounts and rebates.
  • Regulatory Compliance: Adherence to FDA regulations is essential for maintaining market presence.
  • Technological Impact: Advances in technology are reducing development costs and speeding up the drug development process.

FAQs

Q: What is the National Drug Code (NDC) and its significance? A: The NDC is a unique three-segment number that serves as the FDA’s identifier for drugs, helping in the tracking and regulation of drug products.

Q: How does AI impact drug development? A: AI accelerates the drug development process by analyzing vast datasets, predicting molecular structure changes, and reducing costs, thereby speeding up the journey from lab to market.

Q: What are the key trends shaping the pharmaceutical industry in 2025? A: Key trends include the use of AI, personalized medicine, gene editing, and digital tools to improve efficiencies and patient care.

Q: How do generic and biosimilar drugs affect the market? A: Generic and biosimilar drugs can reduce the prices of branded drugs and impact their sales, as seen in the NSCLC market with drugs like Tarceva and Alimta.

Q: What role does regulatory compliance play in drug pricing and market presence? A: Regulatory compliance is essential for maintaining market presence, as non-compliance can result in a drug product not being included in the NDC Directory.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. New Prescription Drug Price Reporting - Minnesota Department of Health
  3. The Future of Pharma: 2025's Key Trends To Know - Laboratorios Rubio
  4. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - Drug Development
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.